AI-generated summary
In this placebo-controlled randomized trial of children and adolescents with cancer who developed chemotherapy-induced oral mucositis, the authors report that low-intensity laser therapy at 830 nm was associated with shorter mucositis duration (5.8 days) than sham treatment (8.9 days). The authors note the sample was small, with only 21 evaluable patients.
- Participants
- 21
- Who or what was studied
- Children and adolescents with cancer receiving chemotherapy or hematopoietic stem-cell transplantation who developed oral mucositis
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The trial was small, with only 21 evaluable patients split between a 9-patient laser group and a 12-patient placebo group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Placebo-controlled, Oral mucositis, Low-level laser therapy, Sham, Control group, Wavelength, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.